As the interest in the marijuana compound cannabidiol (CBD) continues to rise, 2024 has been a remarkable year for research into its potential benefits and applications.
Recently we covered the top marijuana studies published so far in 2024, as well as the top THC studies. In this article, we will cover what we believe to be the most important CBD-related studies released this year.
CBD Alleviates Neurological Deficits Following Traumatic Brain Injury
A study published earlier this year in the Journal of Neurotrauma “underscores CBD’s potential therapeutic role in traumatic brain injury management.”
Prenatal CBD May Block Autism Traits in At-Risk Babies
Researchers at the University of Colorado Boulder found that “Broad-spectrum cannabidiol oil given during pregnancy decreased scores for all three autism spectrum disorder (ASD)-related behavioral responses, resulting in an overall significant prevention of the ASD-like phenotype.” They conclude that these findings “highlight the potential of broad-spectrum cannabidiol oil as a complementary and integrative approach for prevention of stressor-induced sequelae relevant to development of an ASD-like phenotype.”
CBD Boosts Effectiveness of Chemotherapy in Prostate Cancer Treatment
A study conducted by researchers at Suleyman Demirel University in Türkiye and published by the US National Library of Medicine found that CBD may significantly enhance the effectiveness of the chemotherapy drug etoposide in treating prostate cancer.
CBD Significantly Reduces Pain in Veterans
A study conducted by researchers at the University of North Dakota and the Veteran Health Administration revealed promising results regarding the use of cannabidiol (CBD) among veterans experiencing chronic pain.
Clinical Trial: CBD Provides Sustained Relief From Menstrual-Related Symptoms
According to a clinical trial published in the journal Experimental and Clinical Psychopharmacology, consuming soft-gel caps containing CBD is associated with the persistent alleviation of menstrual-related symptoms (MRS).
CBD Reduced the Cognitive Deficits Caused by Fragile X Syndrome
A study published in the journal Pharmacological Research found that “CBD rescued the cognitive deficits displayed by juvenile animals, without inducing tolerance after repeated administration.” These findings “demonstrate that CBD reduced cognitive deficits in a rat model of FXS and provide initial mechanistic insights into its therapeutic potential in neurodevelopmental disorders.”
CBD Oil Improves Symptoms in Children with Moderate to Severe Autism
A study published in the journal Pharmaceuticals found that high-CBD, full-spectrum cannabis extract can improve the symptoms of moderate to severe non-syndromic Autism Spectrum Disorder (ASD) in children and adolescents.
CBD May Help Manage Cholesterol Levels and Reduce the Risk of Atherosclerosis
A study published this year in the journal Molecular Nutrition & Food Research and available on the US National Institute of Health’s website, revealed that cannabidiol (CBD) may play a crucial role in improving cholesterol homeostasis and lipid metabolism in macrophages.
Clinical Trial: Oral CBD is Safe and Effective at Treating Anxiety
According to an Asian Journal of Psychiatry study, the administration of oral CBD is safe and effective for patients suffering from mild to moderate anxiety disorders.
CBD May Protect Against Sepsis-Induced Renal Damage
A study published in the peer-reviewed journal Naunyn-Schmiedeberg’s Archives of Pharmacology “underscores CBD as a promising protective agent against sepsis-induced renal damage.”
Honorable Mentions:
76% of Lennox-Gastaut Syndrome Patients Experience 50% or More Reduction in Seizures With CBD
CBD-Rich Cannabis Oil Enhances Social Interaction in Animal Model
Clinical Trial: CBD is Effective at Treating Acute Toothaches
